Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

G Remington

Showing results (11-20 of 98) with videos related to

Pageof 10
Sort By:
Progress in Neuro-Psychopharmacology & Biological Psychiatry|April 11, 2001
Health care utilization in patients with schizophrenia maintained on atypical versus conventional antipsychoticsG Remington, I Khramov
The American Journal of Psychiatry|April 1, 1996
Serotonin-dopamine interaction and its relevance to schizophreniaS Kapur, G Remington
Pharmacology, Biochemistry, and Behavior|June 1, 1976
A simple method for quantifying tremor in rodentsG Remington, H Anisman
Pharmacology, Biochemistry, and Behavior|May 1, 1974
Disruptive effects of epinephrine on active avoidance behavior: alteration by scopolamine and d-amphetamineG Remington, H Anisman
Annual Review of Medicine|February 13, 2001
Atypical antipsychotics: new directions and new challenges in the treatment of schizophreniaS Kapur, G Remington
The Journal of Clinical Psychiatry|May 26, 1999
D2 and 5-HT2 receptor effects of antipsychotics: bridging basic and clinical findings using PETG Remington, S Kapur
Current Opinion in Investigational Drugs (London, England : 2000)|January 5, 2002
SB-277011 GlaxoSmithKlineG Remington, S Kapur
Canadian Journal of Psychiatry. Revue Canadienne De Psychiatrie|November 6, 2001
Electroconvulsive therapy in cases of treatment-resistant psychosisV Parker, G Remington
Biological Psychiatry|December 18, 2001
Dopamine D(2) receptors and their role in atypical antipsychotic action: still necessary and may even be sufficientS Kapur, G Remington
Journal of Clinical Psychopharmacology|October 1, 1994
Risperidone and obsessive-compulsive symptomsG Remington, M Adams
Pageof 10

Showing results (11-20 of 98) with videos related to

Sort By:
Pageof 10
Progress in Neuro-Psychopharmacology & Biological Psychiatry|April 11, 2001
Health care utilization in patients with schizophrenia maintained on atypical versus conventional antipsychoticsG Remington, I Khramov
The American Journal of Psychiatry|April 1, 1996
Serotonin-dopamine interaction and its relevance to schizophreniaS Kapur, G Remington
Pharmacology, Biochemistry, and Behavior|June 1, 1976
A simple method for quantifying tremor in rodentsG Remington, H Anisman
Pharmacology, Biochemistry, and Behavior|May 1, 1974
Disruptive effects of epinephrine on active avoidance behavior: alteration by scopolamine and d-amphetamineG Remington, H Anisman
Annual Review of Medicine|February 13, 2001
Atypical antipsychotics: new directions and new challenges in the treatment of schizophreniaS Kapur, G Remington
The Journal of Clinical Psychiatry|May 26, 1999
D2 and 5-HT2 receptor effects of antipsychotics: bridging basic and clinical findings using PETG Remington, S Kapur
Current Opinion in Investigational Drugs (London, England : 2000)|January 5, 2002
SB-277011 GlaxoSmithKlineG Remington, S Kapur
Canadian Journal of Psychiatry. Revue Canadienne De Psychiatrie|November 6, 2001
Electroconvulsive therapy in cases of treatment-resistant psychosisV Parker, G Remington
Biological Psychiatry|December 18, 2001
Dopamine D(2) receptors and their role in atypical antipsychotic action: still necessary and may even be sufficientS Kapur, G Remington
Journal of Clinical Psychopharmacology|October 1, 1994
Risperidone and obsessive-compulsive symptomsG Remington, M Adams
Pageof 10